According to Vincerx Pharma's latest financial reports the company has $5.11 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $52.45 M | -52.93% |
2021-12-31 | $0.11 B | 80.38% |
2020-12-31 | $61.79 M | |
2019-12-31 | $N/A |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Nymox Pharmaceutical NYMX | $0.13 M | -97.42% | Bahamas |
![]() NRC Health
NRC | $1.69 M | -66.75% | ๐บ๐ธ USA |